• Is there a fee to be part of Trans-Hit Bio’s network of biospecimen providers ?
    No. There are no fees to be part of THB’s network of biospecimen providers.
  • What criteria does Trans-Hit Bio consider for academic, hospital and clinical sources to become part of our network of biospecimen providers?
    Biospecimen providers in THB’s network are established organizations that comply with local, national and international regulations and guidelines pertaining to the collecting and release of biospecimens for research. All biospecimens must be collected and supplied under appropriate IRB or ethical committee approval. It is advantageous for providers to secure relevant accreditation or certification.
  • Is there any obligation for providers to release biospecimens when partnering with THB?
    No, there is no obligation. For each biospecimen request, the biospecimen providers decide whether they want to participate and release biospecimens for the research project or not.
  • What type of biospecimens, or specific diseases, are the researchers that approach Trans-Hit Bio looking for?
    THB receives biospecimen requests from a varied list of researchers. We receive requests for all kinds of specimens pertaining to every type of disease. The most common disease, relating to the biospecimen requests we receive, is cancer.
  • What data are biospecimen providers expected to provide with their samples?
    The associated data required by researchers varies. Some require basic associated clinical data, such as age and gender, while others require more complex data that can include genetic and clinical follow-up data.
  • How are the costs associated with acquiring biospecimens for research defined?
    At THB, we adhere to the notion that human tissue is not merchandisable. The costs involved with acquiring biospecimens for research relates directly to the costs involved in collecting, analyzing, handling, storing, and transporting biospecimen samples as per the requirements of any given research study. It follows that the costs associated with acquiring samples depends on the type of preparation and the depth of associated data required for the biospecimens in question. At THB, our expert advisors are happy to help you establish biospecimen pricing that reflects these costs and remains attractive to prospective researchers.
  • Are biospecimen providers informed of who is requesting the biospecimens and what kind of research will be implemented with them?
    Yes. Trans-Hit Bio’s model is based on all parties’ interest in transparency. The biospecimen providers are always informed of who the end-user of the biospecimens will be. Biospecimen providers can also request additional information about the research project for which their biospecimens are being provided.
  • Do providers interact directly with the end-users of the requested biospecimen samples?
    Most of the interaction that occurs between providers and researchers is through Trans-Hit Bio. THB has the experience and expertise to navigate the complexities associated with the provision of requested samples. If necessary, THB can set up a teleconference between all parties to discuss scientific or technical details.
  • What is the process for transporting biospecimens to the end-user?
    Biospecimen samples are transported directly from the biospecimen provider to the end-user. Samples are not shipped to THB. This eliminates extra logistical steps exposing your samples to less risk before arriving at destination. THB acts as an intermediary, streamlining this process by supervising all transport logistics. To ensure the highest standards of biospecimen transport, we work with experienced and reputed couriers.